F
Francesco E. Pontieri
Researcher at Sapienza University of Rome
Publications - 140
Citations - 8326
Francesco E. Pontieri is an academic researcher from Sapienza University of Rome. The author has contributed to research in topics: Parkinson's disease & Dopaminergic. The author has an hindex of 35, co-authored 128 publications receiving 7542 citations. Previous affiliations of Francesco E. Pontieri include National Institutes of Health & University of Cagliari.
Papers
More filters
Journal ArticleDOI
Drug addiction as a disorder of associative learning. Role of nucleus accumbens shell/extended amygdala dopamine.
G. Di Chiara,Gianluigi Tanda,Valentina Bassareo,Francesco E. Pontieri,Elio Maria Gioachino Acquas,Sandro Fenu,C Cadoni,E. Carboni +7 more
TL;DR: Addiction is the expression of the excessive control over behavior acquired by drug‐related stimuli as a result of abnormal strenghtening of stimulus‐drug contingencies by nondecremental drug‐induced stimulation of dopamine transmission in the nucleus accumbens shell.
Journal ArticleDOI
The progression of non-motor symptoms in Parkinson's disease and their contribution to motor disability and quality of life.
Angelo Antonini,Paolo Barone,Roberto Marconi,Letterio Morgante,Salvatore Zappulla,Francesco E. Pontieri,Silvia Ramat,Maria Gabriella Ceravolo,Giuseppe Meco,Giulio Cicarelli,Massimo Pederzoli,M. Manfredi,Roberto Ceravolo,M. Mucchiut,Giampiero Volpe,Giovanni Abbruzzese,Edo Bottacchi,Luigi Bartolomei,Giuseppe Ciacci,Antonino Cannas,Maria Giovanna Randisi,Alfredo Petrone,Mario Baratti,Vincenzo Toni,Giovanni Cossu,Paolo Del Dotto,Anna Rita Bentivoglio,Michele Abrignani,R. Scala,Franco Pennisi,Rocco Quatrale,Rosa M. Gaglio,Alessandra Nicoletti,Michele Perini,Tania P. Avarello,Antonio Pisani,Augusto Scaglioni,Paolo Martinelli,Francesco Iemolo,L. Ferigo,P. Simone,Paola Soliveri,Biagio Troianiello,Domenico Consoli,Alessandro Mauro,Leonardo Lopiano,Giuseppe Nastasi,Carlo Colosimo +47 more
TL;DR: Overall non-motor symptom progression does not follow motor deterioration, is symptom-specific, and only development of specific domains negatively impacts quality of life, which has consequences for drug studies targeting non-Motor features.
Journal ArticleDOI
Contribution of blockade of the noradrenaline carrier to the increase of extracellular dopamine in the rat prefrontal cortex by amphetamine and cocaine.
TL;DR: It is suggested that amphetamine and cocaine increase extracellular DA in the PFCX largely through the blockade of the NA carrier, and direct evidence for this hypothesis was provided by the observation that, when theNA carrier was blocked by reverse dialysis of the P FCX with desipramine, cocaine and GBR 12909 lost their differences in the ability to increase extracllular DA.
Journal ArticleDOI
Non-motor symptoms in atypical and secondary parkinsonism: the PRIAMO study.
Carlo Colosimo,Letterio Morgante,Angelo Antonini,Paolo Barone,Tania P. Avarello,Edo Bottacchi,Antonino Cannas,Maria Gabriella Ceravolo,Roberto Ceravolo,Giulio Cicarelli,Rosa M. Gaglio,Luisa Giglia,Francesco Iemolo,M. Manfredi,Giuseppe Meco,Alessandra Nicoletti,Massimo Pederzoli,Alfredo Petrone,Antonio Pisani,Francesco E. Pontieri,Rocco Quatrale,Silvia Ramat,R. Scala,Giampiero Volpe,Salvatore Zappulla,Anna Rita Bentivoglio,Fabrizio Stocchi,Giorgio Trianni,Paolo Del Dotto,Lucia Simoni,Roberto Marconi +30 more
TL;DR: Prevalence and clinical characteristics of NMS in patients with atypical and secondary parkinsonism and the prevalence of skin and respiratory disorders was rather low in all forms, ranging between 10 and 30%.
Journal ArticleDOI
Riluzole in cerebellar ataxia: a randomized, double-blind, placebo-controlled pilot trial
Giovanni Ristori,Silvia Romano,Andrea Visconti,Stefania Cannoni,Maria Spadaro,Marina Frontali,Francesco E. Pontieri,Nicola Vanacore,Marco Salvetti +8 more
TL;DR: This study provides Class I evidence that riluzole reduces, by at least 5 points, the International Cooperative Ataxia Rating Scale (ICARS) score in patients with a wide range of disorders that cause cerebellar ataxia.